Evidence map›Paper›PMID 31928070›Full record

ArticleCirculation. Genomic and precision medicine2020

Deep Mutational Scan of an

Andrew M Glazer, Brett M Kroncke, Kenneth A Matreyek, Tao Yang, Yuko Wada, Tiffany Shields, Joe-Elie Salem, Douglas M Fowler, Dan M Roden

Open access · bronzeAbstract read
In one paragraph

Article in Circulation. Genomic and precision medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Deep mutational scan of the pore of the cold-sensing TRPM8 channel.bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Mapping the Functional Landscape ofmedRxiv : the preprint server for health sciences · 2025
    Article
  10. Functional Profiling ofCirculation. Genomic and precision medicine · 2025
    Article
  11. MaveMD: A functional data resource for genomic medicine.medRxiv : the preprint server for health sciences · 2025
    Article
  12. Surface delivery quantification reveals distinct trafficking efficiencies among clustered protocadherin isoforms.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Andrew M GlazerDepartment of Medicine, Division of Clinical Pharmacology, Vanderbilt Center for Arrhythmia Research and Therapeutics (A.M.G., B.M.K., T.Y., Y.W., T.S., J.-E.S., D.M.R.), Vanderbilt University Medical Center, Nashville, TN.
Brett M KronckeDepartment of Medicine, Division of Clinical Pharmacology, Vanderbilt Center for Arrhythmia Research and Therapeutics (A.M.G., B.M.K., T.Y., Y.W., T.S., J.-E.S., D.M.R.), Vanderbilt University Medical Center, Nashville, TN.
Kenneth A MatreyekDepartment of Genome Sciences, University of Washington, Seattle (K.A.M., D.M.F.).
Tao YangDepartment of Medicine, Division of Clinical Pharmacology, Vanderbilt Center for Arrhythmia Research and Therapeutics (A.M.G., B.M.K., T.Y., Y.W., T.S., J.-E.S., D.M.R.), Vanderbilt University Medical Center, Nashville, TN.
Yuko WadaDepartment of Medicine, Division of Clinical Pharmacology, Vanderbilt Center for Arrhythmia Research and Therapeutics (A.M.G., B.M.K., T.Y., Y.W., T.S., J.-E.S., D.M.R.), Vanderbilt University Medical Center, Nashville, TN.
Tiffany ShieldsDepartment of Medicine, Division of Clinical Pharmacology, Vanderbilt Center for Arrhythmia Research and Therapeutics (A.M.G., B.M.K., T.Y., Y.W., T.S., J.-E.S., D.M.R.), Vanderbilt University Medical Center, Nashville, TN.
Joe-Elie SalemDepartment of Medicine, Division of Clinical Pharmacology, Vanderbilt Center for Arrhythmia Research and Therapeutics (A.M.G., B.M.K., T.Y., Y.W., T.S., J.-E.S., D.M.R.), Vanderbilt University Medical Center, Nashville, TN.
Douglas M FowlerDepartment of Genome Sciences, University of Washington, Seattle (K.A.M., D.M.F.).
Dan M RodenDepartment of Medicine, Division of Clinical Pharmacology, Vanderbilt Center for Arrhythmia Research and Therapeutics (A.M.G., B.M.K., T.Y., Y.W., T.S., J.-E.S., D.M.R.), Vanderbilt University Medical Center, Nashville, TN.
Vanderbilt University Medical Center · US

Funding

Understanding and preventing HLA-associated drug reactionsP50GM115305 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DENNY, JOSHUA C. · 2015 to 2019
$13.0M
Functional Genomics of Cardiac Sodium Channel VariantsR01HL149826 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RODEN, DAN M · 2020 to 2023
$2.9M
Large-Scale Methods for Assessing the Consequences of Mutations in ProteinsR01GM109110 · NIGMS · UNIVERSITY OF WASHINGTON · PI FOWLER, DOUGLAS M · 2014 to 2021
$2.4M
SCN5A (Nav1.5): Predicting the Consequence of Missense Single- Nucleotide Polymorphisms.R00HL135442 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KRONCKE, BRETT M · 2019 to 2021
$741k
SCN5A (Nav1.5): Predicting the Consequence of Missense Single- Nucleotide Polymorphisms.K99HL135442 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KRONCKE, BRETT M · 2017 to 2018
$242k
A pipeline for identifying disease-causing variants in transmembrane proteinsK99HG010904 · NHGRI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI GLAZER, ANDREW M. · 2020 to 2021
$223k
High-throughput Discovery of Pathogenic Cardiac Sodium Channel VariantsF32HL137385 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI GLAZER, ANDREW M. · 2017 to 2019
$133k
NHGRI NIH HHS K99 HG010904NHLBI NIH HHS F32 HL137385NHLBI NIH HHS K99 HL135442NHLBI NIH HHS R00 HL135442NHLBI NIH HHS R01 HL149826NIGMS NIH HHS P50 GM115305NIGMS NIH HHS R01 GM109110
6 · The paper itself

Abstract

backgroundVariants in ion channel genes have classically been studied in low throughput by patch clamping. Deep mutational scanning is a complementary approach that can simultaneously assess function of thousands of variants.

methodsWe have developed and validated a method to perform a deep mutational scan of variants in

resultsIn preliminary experiments, challenge with 3 drugs (veratridine, brevetoxin, and ouabain) could discriminate wild-type channels from gain- and loss-of-function pathogenic variants. High-throughput sequencing of the pre- and postdrug challenge pools was used to count the prevalence of each variant and identify variants with abnormal function. The deep mutational scan scores identified 40 putative gain-of-function and 33 putative loss-of-function variants. For 8 of 9 variants, patch clamping data were consistent with the scores.

conclusionsThese experiments demonstrate the accuracy of a high-throughput in vitro scan of

Indexed as

MutationCardiotonic AgentsDNA Mutational AnalysisHEK293 CellsHumansMarine ToxinsNAV1.5 Voltage-Gated Sodium ChannelOuabainOxocinsPharmacogenomic TestingPolyether ToxinsVeratridinebrevetoxinCardiotonic AgentsMarine ToxinsNAV1.5 Voltage-Gated Sodium ChannelOuabainOxocinsPolyether ToxinsSCN5A protein, humanVeratridineBrugada syndromehumanslong QT syndromeprevalencesodium channels

Identifiers

PMID31928070
PMCPMC7031040
OpenAlexW3005126321

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.